Rigel Pharmaceuticals Inc — Liquidità (NASDAQ:RIGL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -52.19 M5.88 M-73.76 M-5.74 M31.47 M75.66 M 75.66 M Flussi di cassa derivanti dalle attività di investimento 47.47 M-80.04 M72.78 M-4.3 M4.13 M-92.36 M -92.36 M Liquidità derivante dalle attività di finanziamento 12.57 M62.67 M6.55 M18.37 M-11.64 M601 K 601 K Liquidità libera -53.45 M5.25 M-74.21 M-20.74 M31.11 M75.66 M 75.66 M

Notizie

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Micron and Coinbase among market cap stock movers on Wednesday

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Rigel Q4 2025: crescita annuale del 60%, dati promettenti su MDS

Rigel Q4 2025 slides: 60% annual growth, promising MDS data

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates